141 related articles for article (PubMed ID: 37192842)
1. Preanalytical stability of plasma biomarkers for Alzheimer's disease pathology.
Sunde AL; Alsnes IV; Aarsland D; Ashton NJ; Tovar-Rios DA; De Santis G; Blennow K; Zetterberg H; Kjosavik SR
Alzheimers Dement (Amst); 2023; 15(2):e12439. PubMed ID: 37192842
[TBL] [Abstract][Full Text] [Related]
2. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.
Schindler SE; Karikari TK; Ashton NJ; Henson RL; Yarasheski KE; West T; Meyer MR; Kirmess KM; Li Y; Saef B; Moulder KL; Bradford D; Fagan AM; Gordon BA; Benzinger TLS; Balls-Berry J; Bateman RJ; Xiong C; Zetterberg H; Blennow K; Morris JC
Neurology; 2022 Jul; 99(3):e245-e257. PubMed ID: 35450967
[TBL] [Abstract][Full Text] [Related]
3. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
Stevenson-Hoare J; Heslegrave A; Leonenko G; Fathalla D; Bellou E; Luckcuck L; Marshall R; Sims R; Morgan BP; Hardy J; de Strooper B; Williams J; Zetterberg H; Escott-Price V
Brain; 2023 Feb; 146(2):690-699. PubMed ID: 35383826
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
Chatterjee P; Pedrini S; Ashton NJ; Tegg M; Goozee K; Singh AK; Karikari TK; Simrén J; Vanmechelen E; Armstrong NJ; Hone E; Asih PR; Taddei K; Doré V; Villemagne VL; Sohrabi HR; Zetterberg H; Masters CL; Blennow K; Martins RN
Alzheimers Dement; 2022 Jun; 18(6):1141-1154. PubMed ID: 34494715
[TBL] [Abstract][Full Text] [Related]
5. Impact of pre-analytical sample handling factors on plasma biomarkers of Alzheimer's disease.
Kurz C; Stöckl L; Schrurs I; Suridjan I; Gürsel SÜ; Bittner T; Jethwa A; Perneczky R
J Neurochem; 2023 Apr; 165(1):95-105. PubMed ID: 36625424
[TBL] [Abstract][Full Text] [Related]
6. Effect of Long-Term Storage on the Reliability of Blood Biomarkers for Alzheimer's Disease and Neurodegeneration.
Schubert CR; Paulsen AJ; Pinto AA; Merten N; Cruickshanks KJ
J Alzheimers Dis; 2022; 85(3):1021-1029. PubMed ID: 34924380
[TBL] [Abstract][Full Text] [Related]
7. Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.
Meyer PF; Ashton NJ; Karikari TK; Strikwerda-Brown C; Köbe T; Gonneaud J; Pichet Binette A; Ozlen H; Yakoub Y; Simrén J; Pannee J; Lantero-Rodriguez J; Labonté A; Baker SL; Schöll M; Vanmechelen E; Breitner JCS; Zetterberg H; Blennow K; Poirier J; Villeneuve S;
Ann Neurol; 2022 Apr; 91(4):548-560. PubMed ID: 35084051
[TBL] [Abstract][Full Text] [Related]
8. Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals.
Brum WS; Ashton NJ; Simrén J; di Molfetta G; Karikari TK; Benedet AL; Zimmer ER; Lantero-Rodriguez J; Montoliu-Gaya L; Jeromin A; Aarsand AK; Bartlett WA; Calle PF; Coşkun A; Díaz-Garzón J; Jonker N; Zetterberg H; Sandberg S; Carobene A; Blennow K
Alzheimers Dement; 2024 Feb; 20(2):1284-1297. PubMed ID: 37985230
[TBL] [Abstract][Full Text] [Related]
9. Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
Johansson C; Thordardottir S; Laffita-Mesa J; Rodriguez-Vieitez E; Zetterberg H; Blennow K; Graff C
Brain; 2023 Mar; 146(3):1132-1140. PubMed ID: 36626935
[TBL] [Abstract][Full Text] [Related]
10. Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye.
Bai J; Wan Z; Wang M; Wu X; Wang T; Zhang Y; Xue Y; Xu H; Peng Q
Front Aging Neurosci; 2022; 14():1027705. PubMed ID: 36408096
[TBL] [Abstract][Full Text] [Related]
11. Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia.
Silva-Spínola A; Lima M; Leitão MJ; Bernardes C; Durães J; Duro D; Tábuas-Pereira M; Santana I; Baldeiras I
Eur J Neurol; 2023 Jun; 30(6):1565-1573. PubMed ID: 36880887
[TBL] [Abstract][Full Text] [Related]
12. Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.
Sun Q; Ni J; Wei M; Long S; Li T; Fan D; Lu T; Shi J; Tian J
Front Aging Neurosci; 2022; 14():963845. PubMed ID: 36062146
[TBL] [Abstract][Full Text] [Related]
13. Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
Panikkar D; Vivek S; Crimmins E; Faul J; Langa KM; Thyagarajan B
J Alzheimers Dis; 2023; 95(2):735-748. PubMed ID: 37574735
[TBL] [Abstract][Full Text] [Related]
14. Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum.
Zhang M; Chen H; Huang W; Guo T; Ma G; Han Y; Shu N
Hum Brain Mapp; 2024 Jan; 45(1):e26566. PubMed ID: 38224535
[TBL] [Abstract][Full Text] [Related]
15. Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.
Li X; Yucel R; Clervius H; Kamalakar K; Zetterberg H; Blennow K; Zhang J; Adimora A; Collins LF; Fischl M; Kassaye S; Maki P; Seaberg E; Sharma A; Vance D; Gustafson DR
JAMA Netw Open; 2023 Nov; 6(11):e2344194. PubMed ID: 38019518
[TBL] [Abstract][Full Text] [Related]
16. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
Huang Y; Li Y; Xie F; Guo Q
CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638
[TBL] [Abstract][Full Text] [Related]
17. The accuracy and robustness of plasma biomarker models for amyloid PET positivity.
Benedet AL; Brum WS; Hansson O; ; Karikari TK; Zimmer ER; Zetterberg H; Blennow K; Ashton NJ
Alzheimers Res Ther; 2022 Feb; 14(1):26. PubMed ID: 35130933
[TBL] [Abstract][Full Text] [Related]
18. Levels of Alzheimer's disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults.
Huber H; Ashton NJ; Schieren A; Montoliu-Gaya L; Molfetta GD; Brum WS; Lantero-Rodriguez J; Grötschel L; Stoffel-Wagner B; Coenen M; Weinhold L; Schmid M; Blennow K; Stehle P; Zetterberg H; Simon MC
Alzheimers Dement; 2023 Dec; 19(12):5531-5540. PubMed ID: 37243891
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.
Bilgel M; An Y; Walker KA; Moghekar AR; Ashton NJ; Kac PR; Karikari TK; Blennow K; Zetterberg H; Jedynak BM; Thambisetty M; Ferrucci L; Resnick SM
Alzheimers Dement; 2023 Oct; 19(10):4335-4345. PubMed ID: 37216632
[TBL] [Abstract][Full Text] [Related]
20. Plasma Core Alzheimer's Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline.
Ni M; Zhu ZH; Gao F; Dai LB; Lv XY; Wang Q; Zhu XX; Xie JK; Shen Y; Wang SC; Xie Q;
ACS Chem Neurosci; 2023 Jan; 14(1):170-179. PubMed ID: 36547971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
